Advaxis to Present at LD Micro Main Event
November 28 2018 - 8:00AM
Business Wire
Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology
company focused on the discovery, development and commercialization
of immunotherapy products, today announced that Kenneth A. Berlin,
President and Chief Executive Officer of Advaxis, will present a
corporate overview at the 11th Annual LD Micro Main Event on
Tuesday, December 4, 2018 at 5:00 p.m. (Pacific). The conference
will be held on December 4-6, 2018 at the Luxe Sunset Bel-Air,
California.
Mr. Berlin’s presentation will be webcast live and available for
replay in the Investors section of the Company’s website at
www.ir.advaxis.com.
About Advaxis, Inc.
Advaxis, Inc. is a late-stage biotechnology company focused on
the discovery, development and commercialization of
proprietary Lm-based antigen delivery products. These
immunotherapies are based on a platform technology that utilizes
live attenuated Listeria monocytogenes (Lm) bioengineered to
secrete antigen/adjuvant fusion proteins. These Lm-based
strains are believed to be a significant advancement in
immunotherapy as they integrate multiple functions into a single
immunotherapy and are designed to access and direct antigen
presenting cells to stimulate anti-tumor T cell immunity, activate
the immune system with the equivalent of multiple adjuvants, and
simultaneously reduce tumor protection in the tumor
microenvironment to enable the T cells to eliminate tumors. Advaxis
has four franchises in various stages of clinical and preclinical
development: HPV-associated cancers, personalized
neoantigen-directed immunotherapy, off-the-shelf, hotspot/cancer
antigens neoantigen-directed immunotherapy and prostate cancer.
To learn more about Advaxis, visit www.advaxis.com and connect
on Twitter, LinkedIn, Facebook and YouTube.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181128005099/en/
Investors:LHA Investor RelationsMiriam Weber Miller,
212-838-3777mmiller@lhai.com
Ayala Pharmaceuticals (QX) (USOTC:ADXS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ayala Pharmaceuticals (QX) (USOTC:ADXS)
Historical Stock Chart
From Apr 2023 to Apr 2024